Azitra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Azitra and other ETFs, options, and stocks.About AZTR
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin.
CEOFrancisco D. Salva
CEOFrancisco D. Salva
Employees12
Employees12
HeadquartersBranford, Connecticut
HeadquartersBranford, Connecticut
Founded2014
Founded2014
Employees12
Employees12
AZTR Key Statistics
Market cap3.52M
Market cap3.52M
Price-Earnings ratio-0.13
Price-Earnings ratio-0.13
Dividend yield—
Dividend yield—
Average volume4.24M
Average volume4.24M
High today$1.52
High today$1.52
Low today$0.7111
Low today$0.7111
Open price$1.28
Open price$1.28
Volume108.26M
Volume108.26M
52 Week high$4.93
52 Week high$4.93
52 Week low$0.7015
52 Week low$0.7015
AZTR News
TipRanks 6h
Azitra Stock Rockets on Clinical Trial UpdateAzitra (AZTR) stock rocketed higher on Wednesday after the company announced an update to a Phase 1/2 clinical trial of ATR04-484. ATR04-484 is a topically appl...
TipRanks 8h
Azitra doses first patient in Phase 1/2 clinical trial of ATR04-484Azitra (AZTR) announced the dosing of the first patient in its Phase 1/2 clinical trial of ATR04-484, a topically applied live biotherapeutic product candidate...
Benzinga 6d
Why Azitra Stock Shot Up 59% After-Hours?Azitra Inc. AZTR shares skyrocketed 58.71% in after-hours trading to $1.51 on Thursday, following the implementation of a 1-for-6.66 reverse stock split and sig...
People also own
Based on the portfolios of people who own AZTR. This list is generated using Robinhood data, and it’s not a recommendation.